Wolverine Trading, LLC Arcturus Therapeutics Holdings Inc. Call Options Transaction History

Wolverine Trading, LLC

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$18.08 - $25.38 $233,231 - $327,402	12,900 New	12,900 $299,000
Q4 2023 Feb 14, 2024	BUY	$17.71 - $32.97 $58,443 - $108,801	3,300 Added 39.29%	11,700 $368,000
Q3 2023 Nov 15, 2023	BUY	$25.44 - $37.35 $213,696 - $313,740	8,400 New	8,400 $214,000
Q2 2022 Aug 15, 2022	SELL	$12.26 - $31.17 $204,742 - $520,539	-16,700 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$17.64 - $39.57 $89,964 - $201,807	-5,100 Reduced 23.39%	16,700 $460,000
Q4 2021 Feb 14, 2022	BUY	$34.2 - $47.56 $745,560 - $1.04 Million	21,800 New	21,800 $848,000
Q2 2021 Aug 06, 2021	SELL	$25.79 - $42.11 $693,751 - $1.13 Million	-26,900 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$38.75 - $86.92 $1.06 Million - $2.38 Million	-27,400 Reduced 50.46%	26,900 $1.04 Million
Q4 2020 Feb 12, 2021	BUY	$34.61 - $123.66 $1.08 Million - $3.87 Million	31,300 Added 136.09%	54,300 $2.54 Million
Q3 2020 Nov 13, 2020	BUY	$37.49 - $63.19 $48,737 - $82,147	1,300 Added 5.99%	23,000 $983,000
Q2 2020 Aug 13, 2020	BUY	$12.66 - $58.27 $110,142 - $506,949	8,700 Added 66.92%	21,700 $1.02 Million
Q4 2019 Feb 12, 2020	BUY	$8.93 - $12.41 $116,090 - $161,330	13,000 New	13,000 $135,000

179

25.6M

195K

133K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $439M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.